Evolus Inc (EOLS) stock news · rev $297.2M
Evolus Inc (EOLS) is a drug manufacturers - specialty & generic company listed on US.
This EOLS news page leads with what Evolus Inc filed — not a scraped headline mill.
No cached 8-K sentence for EOLS yet. We will not pad this page with generic market recap.
Latest reported EOLS revenue for 2025-12-31 was $297.2M. Net income was -$51.6M. Revenue was up 11.6% from 2024-12-31 to 2025-12-31. EOLS currently screens at market cap $597.0M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the EOLS stock page; for the tape open the quote page.
EOLS stock news FAQ
What are EOLS's latest revenue and net income?
Latest cached Evolus Inc (EOLS) revenue for Dec 31, 2025 was $297.2M. Net income was -$51.6M. Statements: https://lician.com/financials/eols
How did EOLS revenue change from the prior cached period?
Cached Evolus Inc (EOLS) revenue was up 11.6% from $266.3M (Dec 31, 2024) to $297.2M (Dec 31, 2025). Statements: https://lician.com/financials/eols
What is EOLS's market cap?
Evolus Inc (EOLS) market cap is $597.0M on the latest cached fundamentals snapshot.
What kind of company is EOLS?
Evolus Inc (EOLS) is a drug manufacturers - specialty & generic company listed on US.
Where is EOLS stock news listed?
Cached stock news for Evolus Inc (EOLS) is listed at https://lician.com/news/eols. Filings: https://lician.com/sec/eols
Not investment advice.